drugset / Trial / NCT01433393
Double-blind Comparative Study of TAK-875
Parallel-group
Summary
The purpose of this study is to evaluate the efficacy and safety of treatment with TAK-875 in diabetic patients.
Timeline
- Start
- —
- Primary completion
- 2012-09
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fasiglifam | Small molecule | 25 mg | — |
| Subject | Fasiglifam | Small molecule | 50 mg | — |